The enhancement of recombinant antibody production in Chinese Hamster Ovary (CHOK1) cells is a crucial aspect of biopharmaceutical development. To maximize efficacy, various methods are employed, including molecular engineering of the host cells and optimization of media conditions. Additionally, utilization of advanced production systems can sig